TeleDaaS debuts as dosimetry provider at RSNA 2023

Dosimetry-as-a-service provider TeleDaaS made its official debut at RSNA 2023.

The Evanston, IL-based company specializes in delivering dosimetry analysis and treatment plans to clinical research organizations and pharmaceutical manufacturers.

The company offers scalable dosimetry services that integrate with existing imaging workflows in hospitals and cancer treatment research facilities. TeleDaaS uses proprietary software from Mirada Medical, which integrates with standard imaging technology, to support clinical trial design, execution, and the development of new targeted radiation therapies.

Page 1 of 461
Next Page